智通财经APP讯，VITASOY INT'L(00345)发布公告，于2025年10月8日斥资1.6万港元回购2000股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年10月8日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 維他奶國際集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 不適用 FF301 第 1 頁 共 11 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,049,545,089 | | 0 | | 1,049,545,089 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 1,049,545,089 | | 0 | | 1,049,545 ...

Summary of Key Points from the Conference Call Industry Overview - The current consumer market is expected to recover gradually, with many companies entering a bottoming phase. The liquor industry is projected to see a turning point by Q1 2026, while health foods, dairy products, and small-cap companies present significant investment opportunities [17][19] Core Insights and Arguments - **Food and Consumer Stocks**: Anticipated decline in holdings for food and consumer stocks to historical lows in Q3 2025, with active holdings expected to be very low. This trend may continue for several quarters, eventually forming a bottom [3] - **Investment Opportunities in Food Stocks**: Significant investment opportunities are expected in food stocks next year, with valuations potentially dropping below 15 times earnings and price-to-sales ratios between 1 to 3 times, especially for companies with stable revenues and strong market shares [5][12] - **Liquor and Traditional Consumer Goods**: The liquor industry may have recovery opportunities next year if Q4 reports show positive results. The traditional Chinese medicine sector, despite poor performance this year, has low valuations and strong pricing power, suggesting a faster recovery than other sectors [6][8] - **Health Food Sector**: The health food sector has performed well this year, with companies like Chengfang Bio, Baihe, Xianle, and Jindawei showing promise. The integration of pet-related businesses may further enhance growth opportunities [9][11] Noteworthy Companies and Valuations - **Yili Co., Ltd.**: Valuation is attractive, with expected price-to-sales ratios dropping to 1.5-1.7 times next year. The company has a strong cash reserve of over 50 billion to 60 billion, indicating potential for value creation during bull markets [12] - **Vitasoy International**: Notable for its low price-to-sales ratio of only 2 times and strong cash position, with revenue recovering to 5-6 billion. The company is expected to enhance profitability through management optimization [10] - **Small-Cap Companies**: Companies like Xingye Technology and Tiantie are highlighted for their governance improvements and strong technological capabilities, indicating potential for significant growth [15][16] Challenges and Market Dynamics - **Traditional Consumer Goods**: The traditional consumer sector, including liquor and Chinese medicine, faces challenges due to insufficient product innovation and economic volatility. Many companies are postponing new product launches until 2026 [2][7] - **Market Sentiment**: There is growing concern in the market regarding the performance of traditional consumer goods, particularly with the decline in prices for premium liquor brands like Moutai [2][7] Future Outlook - **Policy Support for Traditional Medicine**: The Chinese medicine sector may improve with policy support and increased capital involvement. Companies with strong cash reserves and high dividend payouts are expected to perform better [8][14] - **Investment Strategy**: The focus will remain on increasing the proportion of small-cap stocks and closely monitoring developments in food, Chinese medicine, non-alcoholic beverages, and liquor sectors [20]

Core Insights - The article narrates the experiences of employees in the fast-moving consumer goods (FMCG) industry, particularly focusing on the challenges faced by those working for PepsiCo and Vitasoy in China, highlighting the impact of corporate changes and market dynamics on their careers [2][3][18]. Group 1: PepsiCo and Its Strategic Alliance - In 2012, PepsiCo formed a strategic alliance with Master Kong, leading to significant changes in operations and employee dynamics within the company [3][5]. - The merger caused unrest among employees, with many fearing for their job security and future compensation, resulting in a mass exodus of nearly 10,000 employees out of 15,000 [6][18]. - The initial promises of job security from Master Kong were not upheld, leading to dissatisfaction and protests among the workforce [5][6]. Group 2: Transition to Vitasoy - After leaving PepsiCo, employees transitioned to Vitasoy, where they initially found a more relaxed corporate culture compared to the rigid structure of PepsiCo [9][10]. - However, Vitasoy faced challenges due to the rise of e-commerce, which disrupted traditional sales channels and led to internal conflicts between online and offline sales teams [11][15]. - The aggressive pricing strategies adopted by Vitasoy for online sales created chaos in the market, leading to complaints from traditional distributors and a breakdown of pricing structures [13][14]. Group 3: Industry Challenges and Employee Sentiment - The internal strife within Vitasoy escalated, with employees feeling the pressure of performance metrics while dealing with a chaotic market environment [16][17]. - The company underwent leadership changes and restructuring efforts that failed to stabilize the situation, resulting in widespread dissatisfaction among employees [17][18]. - Many former employees of the FMCG sector, like the protagonist, chose to leave the industry altogether, seeking more stable and grounded opportunities in different sectors, such as agriculture [18][20].

增持后，Kuang Ming Investments Pte. Limited最新持股数目为115,638,000股，持股比例由10.92%上升至11.02%。 格隆汇9月25日丨根据联交所最新权益披露资料显示，2025年9月19日，维他奶(00345.HK)获Kuang Ming Investments Pte. Limited在场内以每股均价8.5039港元 增持100万股，涉资约850.39万港元。 | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | 持有權益的股份數目 佔已發行的 有關事件的日期材 | | | --- | --- | --- | --- | --- | | | 股份數目 | | | (語参閱 上犹*註 有投票權股(日/月/年) 春 | | | | | | 份自分比 | | | | | | 00 | | CS20250924E00196 | Kuang Ming Investments Pte. 1101(L) | 1.000.000(L) | HKD 8.5039 | 115.638.000(L) 11.02(L) 19/09/20 ...

智通财经APP获悉，香港联交所最新资料显示，9月19日，Kuang Ming Investments Pte. Limited增持维他 奶国际(00345)100万股，每股作价8.5039港元，总金额为850.39万港元。增持后最新持股数目约为1.16亿 股，最新持股比例为11.02%。 （原标题：Kuang Ming Investments Pte. Limited增持维他奶国际(00345)100万股 每股作价约8.5港元） ...

Group 1 - Kuang Ming Investments Pte. Limited increased its stake in Vitasoy International Holdings Limited (00345) by purchasing 1 million shares at a price of HKD 8.5039 per share, totaling HKD 8.5039 million [1] - After the purchase, Kuang Ming Investments holds approximately 116 million shares, representing an ownership stake of 11.02% in Vitasoy International [1]

Group 1 - The article reports on share buybacks conducted by various companies on September 2, 2025, with a total of 30 companies participating in the buyback program [1] - China Hongqiao (01378) had the largest buyback amount, repurchasing 36.65 million shares for a total of 942 million [2] - Tencent Holdings (00700) repurchased 913,000 shares for 550 million, while Hang Seng Bank (00011) bought back 210,000 shares for 23.66 million [2] Group 2 - The cumulative buyback quantity for China Hongqiao (01378) for the year reached 14.1 million shares, representing 1.5% of its total share capital [2] - Other notable buybacks include Vitasoy International (00345) with 718,000 shares for 6.57 million and MGM China (02282) with 1 million shares for 15.90 million [2] - The buyback activity reflects a trend among companies to return capital to shareholders, with varying percentages of total share capital being repurchased across different firms [2][3]

今年以来该股累计进行37次回购，合计回购2564.80万股，累计回购金额2.39亿港元。（数据宝） VITASOY INT'L回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.09.02 | 71.80 | 9.150 | 9.140 | 656.96 | | 2025.09.01 | 50.00 | 9.150 | 9.080 | 456.85 | | 2025.08.11 | 58.20 | 9.260 | 9.200 | 537.89 | | 2025.08.08 | 18.20 | 9.260 | 9.260 | 168.53 | | 2025.08.06 | 17.40 | 9.260 | 9.260 | 161.12 | | 2025.08.05 | 4.60 | 9.260 | 9.170 | 42.31 | | 2025.08.04 | 22.20 | 9.150 | 9.080 | 202.50 | | 2025.08.01 | 184.40 | ...